Maxime Pesant - Profile and Investment Details

Investor Profile

Maxime Pesant is a Venture Capital, Private Equity Firm based in Blainville, Quebec, Canada with a diverse investment portfolio that includes companies such as Salmedix Inc, MethylGene, Copernicus Therapeutics, Cytochroma, NewBiotics, Ceptyr, AgeChem Financial Inc., Elitra Pharmaceuticals, Novalon Pharmaceutical, Message Pharmaceuticals, LymphoSign, GeneFormatics, Gene Logic, Ambit Biosciences, The Medicines Company, Xanthus Pharmaceuticals, Kisoji Biotechnology Inc., Osprey Pharmaceuticals USA, Aegera Therapeutics, Epitopea, Interomex BioPharmaceuticals, enGene, Viron Therapeutics, Lexicon Pharmaceuticals, . Over time, Maxime Pesant has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Maxime Pesant is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Data Integration, Corporate Social Responsibility Management, Enterprise Software, Investment Management, Business Development, Finance, Biotechnology, Innovation, Clinical Trials, Digital Transformation, Consumer Software, Capital Raising, Medical, Information Technology, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Maxime Pesant, as their portfolio suggests a familiarity and interest in this area.

Understanding Maxime Pesant’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.